NAD+ Therapy for Maryland Clinics: Supply & Compliance Guide
Maryland medical practices offering NAD+ subcutaneous injections need a reliable cGMP supply partner. Here is what Maryland providers need to know about ordering NAD+ for their clinic.
Maryland's Baltimore-Washington corridor is home to one of the most sophisticated and health-conscious patient populations in the United States. Concierge medicine practices, functional medicine clinics, and medical spas across the state are adding NAD+ subcutaneous injections as a premium service that complements GLP-1 programs and supports comprehensive longevity medicine protocols.
If you operate a licensed medical practice in Maryland and you're looking to add or expand NAD+ therapy, this guide covers supply standards, regulatory considerations, and how to get your clinic set up.
Why Maryland Clinics Are Adding NAD+ Therapy
Maryland's patient population — particularly in the affluent DC suburbs of Montgomery County and the Baltimore metro — has high health literacy and strong demand for evidence-based longevity and metabolic health services. NAD+ therapy fits naturally into this market.
DC Suburb Concierge Medicine — Bethesda, Rockville, and Chevy Chase concierge medicine practices are among the most active NAD+ users in the Mid-Atlantic region. These practices typically offer NAD+ as part of comprehensive longevity programs combining GLP-1s, peptides, hormone optimization, and advanced diagnostics.
Baltimore Functional Medicine — Baltimore's functional medicine community has embraced NAD+ for energy optimization, cognitive performance, and metabolic health.
Medical Spas — Maryland's growing medical spa industry has added NAD+ as a premium anti-aging service, often positioned alongside aesthetic treatments and GLP-1 programs.
NAD+ Supply Standards for Maryland Clinics
USA cGMP Manufacturing — NAD+ for injection must be manufactured in a cGMP-compliant, FDA-registered USA facility. MedClinic Partners supplies NAD+ exclusively from USA-based cGMP manufacturers.
USP <797> Sterile Compounding — Injectable NAD+ must be compounded under USP <797> sterile conditions. Maryland's sophisticated regulatory environment demands rigorous documentation — request and retain current compliance documentation from your supplier.
Certificate of Analysis — Every lot should include a third-party CoA confirming identity, potency, sterility, and endotoxin levels. MedClinic Partners provides full CoA documentation through the portal for every order.
Lot Traceability — Full lot traceability from raw material to finished product is essential for Maryland practices subject to Maryland Board of Pharmacy oversight or internal audits.
Maryland Regulatory Considerations for NAD+ Therapy
Prescribing Requirements — NAD+ subcutaneous injections require a valid prescription from a licensed Maryland provider. Maryland requires a valid patient-provider relationship and thorough patient documentation for compounded medication prescribing.
Storage Requirements — Compounded NAD+ injectables require refrigeration at 2–8°C. Maryland practices must maintain compliant medication storage logs.
Telehealth Prescribing — Maryland permits telehealth prescribing of compounded medications, including NAD+, provided the prescriber holds an active Maryland license and meets Maryland's telehealth documentation requirements.
NAD+ Protocols Maryland Clinics Are Running
GLP-1 + NAD+ Combination — Maryland clinics are pairing NAD+ with compounded semaglutide or tirzepatide to support mitochondrial function and energy metabolism, particularly beneficial for patients experiencing fatigue during GLP-1 titration.
Executive Health Programs — Maryland's proximity to Washington DC creates strong demand for executive health and corporate wellness programs featuring NAD+ for cognitive performance, energy optimization, and stress resilience.
Longevity Medicine — DC-suburb longevity clinics offer NAD+ as part of comprehensive programs combining GLP-1s, peptides, hormone optimization, and advanced diagnostics.
Cognitive Performance — Maryland concierge medicine practices offer NAD+ for cognitive clarity, focus, and mental performance.
How MedClinic Partners Serves Maryland NAD+ Clinics
We supply USA cGMP NAD+ subcutaneous injections to licensed medical practices throughout Maryland — Baltimore, Bethesda, Rockville, Silver Spring, Annapolis, Frederick, and throughout the Eastern Shore.
Same-Day Portal Access — Maryland providers can apply and receive portal access within 24 hours of NPI verification. NAD+ is available through the same portal as our GLP-1 and peptide products.
Overnight Delivery — All orders ship overnight in temperature-controlled packaging. Maryland deliveries typically arrive before noon the following business day.
Compliance Documentation — Full CoA documentation and lot traceability are available through the portal for every order.
Getting Started as a Maryland Provider
Apply online and receive portal access within 24 hours. Submit your NPI, Maryland license information, and practice details. You'll have access to our full product catalog — NAD+, compounded GLP-1s, and USA cGMP RUO peptides — with transparent wholesale pricing the same day.
Explore Topics
Written by
Ian J.
Co-Founder & Managing Partner — Mass-Tort Pharma Background & Medical Operator
Ian is a co-founder of MedClinic Partners with over a decade of experience in mass-tort pharmaceutical matters and medical practice operations. He has personally overseen the launch and compliance infrastructure of multiple GLP-1 and peptide programs, and brings a unique legal-operational perspective to compounding supply chain management.
Editorial standards: All content on medclinicpartners.com is reviewed by licensed medical operators and compounding compliance specialists before publication. Articles are updated when regulatory guidance changes. This content is for licensed healthcare providers only and does not constitute medical advice.
